EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice

Jacopo Di Lucente iD, Jon J Ramsey iD, Lee-Way Jin iD, Izumi Maezawa iD

FASEB BioAdvances · 2024-12 · 6 (12) · 581-596

DOI: 10.1096/fba.2024-00123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FASEB BioAdvances, online erschienen am 23.10.2024. Verfasst von Jacopo Di Lucente und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine and M.I.N.D. Institute University of California Davis Medical Center Sacramento California USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketotherapeutics is a potential metabolic intervention for mitigating dementias; however, its mechanisms and optimal methods of application are not well understood. Our previous in vitro study showed that β‐hydroxybutyrate (BHB), a major ketone body, reverses pathological features of amyloid‐β oligomer (AβO)‐activated microglia. Here we tested the in vivo effects of BHB on microglia and synaptic plasticity in the 5xFAD Alzheimer's disease (AD) mouse model. A short 1‐week regimen of daily intraperitoneal injection of BHB (250 mg/kg), which induced brief and mild daily episodic ketosis, was sufficient to mitigate pro‐inflammatory microglia activation and reduce brain amyloid‐β deposition by enhancing phagocytosis. Remarkably, it mitigated the deficits of hippocampal long‐term depression but not long‐term potentiation, and this effect was linked to suppression of NLRP3 inflammasome‐generated IL‐1β. As ketogenic diets are known for poor compliance, our study opens the possibility for alternative approaches such as short‐term BHB injections or dietary ketone esters that are less restrictive, potentially safer, and easier for compliance.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer'sketosismetabolismmicrogliasynapse

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine and M.I.N.D. Institute University of California Davis Medical Center Sacramento California USA.
  • Department of Molecular Biosciences University of California Davis California USA.
  • Alzheimer's Disease Research Center University of California Davis Medical Center Sacramento California USA.

ORCID-Profile: Jacopo Di Lucente, Jon J Ramsey, Lee-Way Jin, Izumi Maezawa

Förderung

  • NIA NIH HHS

Zitieren

APA

Di Lucente, J., Ramsey, J. J., Jin, L. W., & Maezawa, I. (2024). The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice. FASEB BioAdvances, 6(12), 581-596. https://doi.org/10.1096/fba.2024-00123

Vancouver

Di Lucente J, Ramsey JJ, Jin LW, Maezawa I. The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice. FASEB BioAdvances. 2024;6(12):581-596. doi:10.1096/fba.2024-00123

BibTeX
@article{DiLucente2024,
  author = {Di Lucente, Jacopo and Ramsey, Jon J and Jin, Lee-Way and Maezawa, Izumi},
  title = {The impact of mild episodic ketosis on microglia and hippocampal long‐term depression in 5xFAD mice},
  journal = {FASEB BioAdvances},
  year = {2024},
  volume = {6},
  number = {12},
  pages = {581--596},
  doi = {10.1096/fba.2024-00123}
}
Kostenlos starten →